Physician

Minhee Cho, M.D.

According to 2025 Medicare claims, Minhee Cho, M.D. (NPI: 1801090709) practices ophthalmology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is WASHINGTON RETINA, PLLC (NPI: 1215672084; TIN: 881667866) and primary practice location at 98002-4035.

Cho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 399 traditional Medicare patients, billed 6,621 HCPCS/CPT codes, and received $750,674 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 490 prescription claims across 181 beneficiaries totaling $16,579 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 9 records totaling $268. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $271,274 and ending at $750,674. Concurrently, Part D prescription costs have declined steadily, from $68,579 to $16,579. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$675K$1.3M2015 Medicare payment: $271,274 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $587,889 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $446,779 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $656,941 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,349,857 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $880,394 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $790,511 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $502,515 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $388,697 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $750,674 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154282,409$271,274
20164553,472$587,889
20173392,667$446,779
20183593,697$656,941
20196957,205$1,349,857
20205854,405$880,394
20215284,060$790,511
20224272,432$502,515
20233013,263$388,697
20243996,621$750,674

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$34K$69K2015 Drug cost: $68,579 (USD; Tot_Drug_Cst)2016 Drug cost: $63,897 (USD; Tot_Drug_Cst)2017 Drug cost: $32,127 (USD; Tot_Drug_Cst)2018 Drug cost: $52,954 (USD; Tot_Drug_Cst)2019 Drug cost: $47,717 (USD; Tot_Drug_Cst)2020 Drug cost: $42,031 (USD; Tot_Drug_Cst)2021 Drug cost: $28,428 (USD; Tot_Drug_Cst)2022 Drug cost: $14,842 (USD; Tot_Drug_Cst)2023 Drug cost: $11,145 (USD; Tot_Drug_Cst)2024 Drug cost: $16,579 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015177594$68,579
2016170636$63,897
2017116387$32,127
2018163578$52,954
2019162529$47,717
2020149505$42,031
2021149400$28,428
202288209$14,842
202359161$11,145
2024181490$16,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye112115$136
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more191191$124
92014Established patient complete exam of visual system201306$102
92134Imaging of retina254563$34
92250Photography of the retina324358$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1676,796$8,218
ValacyclovirValacyclovir Hcl20575$1,706
DifluprednateDifluprednate13304$1,429
OfloxacinOfloxacin851,802$938
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat534,265$667

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$268ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Minhee Cho, M.D.?

Tedicare shows public-source Medicare data for Minhee Cho, M.D. (NPI 1801090709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Minhee Cho, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Minhee Cho, M.D.?

Minhee Cho, M.D. is linked to WASHINGTON RETINA, PLLC (billing NPI 1215672084) in the available physician profile data.

Does Minhee Cho, M.D. have Open Payments data?

Minhee Cho, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.